I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Mayer, Jiří
622
results:
Search for persons
X
Format
Online (622)
Mediatypes
Articles (Online) (297)
Bookchapter (Online) (11)
OpenAccess-fulltext (314)
Languages
english (559)
more...
latin (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
De novo accelerated phase of chronic myeloid leukemia shoul..:
Hornak, Tomas
;
Mayer, Jiri
;
Cicatkova, Petra
...
American Journal of Hematology. 99 (2024) 4 - p. 763-766 , 2024
Link:
https://doi.org/10.1002/..
?
2
MethScore as a new comprehensive DNA methylation-based valu..:
Šestáková, Šárka
;
Šálek, Cyril
;
Kundrát, Dávid
...
Clinical Epigenetics. 16 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
3
Why are not all eligible chronic myeloid leukemia patients ..:
Žáčková, Daniela
;
Semerád, Lukáš
;
Faber, Edgar
...
Leukemia. , 2024
Link:
https://doi.org/10.1038/..
?
4
Health-related quality of life and symptoms of chronic myel..:
Efficace, Fabio
;
Mahon, Francois-Xavier
;
Richter, Johan
...
Leukemia. 38 (2024) 8 - p. 1722-1730 , 2024
Link:
https://doi.org/10.1038/..
?
5
Plain language summary of zanubrutinib or ibrutinib in chro..:
Brown, Jennifer R
;
Eichhorst, Barbara
;
Hillmen, Peter
...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024
Link:
https://doi.org/10.2217/..
?
6
ROP-ET: a prospective phase III trial investigating the eff..:
Kiladjian, Jean-Jacques
;
Marin, Francisca Ferrer
;
Al-Ali, Haifa Kathrin
...
Annals of Hematology. 103 (2024) 7 - p. 2299-2310 , 2024
Link:
https://doi.org/10.1007/..
?
7
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine ..:
Pratz, Keith W.
;
Jonas, Brian A.
;
Pullarkat, Vinod
...
American Journal of Hematology. 99 (2024) 4 - p. 615-624 , 2024
Link:
https://doi.org/10.1002/..
?
8
Management and outcome of patients with chronic myeloid leu..:
Brioli, Annamaria
;
Lomaia, Elza
;
Fabisch, Christian
...
Leukemia. 38 (2024) 5 - p. 1072-1080 , 2024
Link:
https://doi.org/10.1038/..
?
9
Momelotinib vs. ruxolitinib in myelofibrosis patient subgro..:
Gupta, Vikas
;
Oh, Stephen
;
Devos, Timothy
...
Leukemia & Lymphoma. 65 (2024) 7 - p. 965-977 , 2024
Link:
https://doi.org/10.1080/..
?
10
Fungal infection frequency in newly diagnosed acute myeloid..:
Weinbergerová, Barbora
;
Mayer, Jiří
;
Kabut, Tomáš
...
British Journal of Haematology. , 2024
Link:
https://doi.org/10.1111/..
?
11
Changes in bone marrow fibrosis during momelotinib or ruxol..:
Oh, Stephen T.
;
Verstovsek, Srdan
;
Gupta, Vikas
...
eJHaem. 5 (2024) 1 - p. 105-116 , 2024
Link:
https://doi.org/10.1002/..
?
12
Stromal cells engineered to express T cell factors induce r..:
Hoferkova, Eva
;
Seda, Vaclav
;
Kadakova, Sona
...
Leukemia. 38 (2024) 8 - p. 1699-1711 , 2024
Link:
https://doi.org/10.1038/..
?
13
Mutations in myeloid transcription factors and activated si..:
Perusini, Maria Agustina
;
Žáčková, Daniela
;
Kim, Taehyung
...
Blood Advances. 8 (2024) 10 - p. 2361-2372 , 2024
Link:
https://doi.org/10.1182/..
?
14
Long-term treatment with rilzabrutinib in patients with imm..:
Kuter, David J.
;
Mayer, Jiri
;
Efraim, Merlin
...
Blood Advances. 8 (2024) 7 - p. 1715-1724 , 2024
Link:
https://doi.org/10.1182/..
?
15
Incidence, risk factors, and outcomes of second neoplasms i..:
Sobas, Marta
;
Knopinska-Posluszny, Wanda
;
Piątkowska-Jakubas, Beata
...
Annals of Hematology. 103 (2023) 2 - p. 451-461 , 2023
Link:
https://doi.org/10.1007/..
1-15